APA (7th ed.) Citation

James, N. D., Spears, M. R., Clarke, N. W., Dearnaley, D. P., De Bono, J. S., Gale, J., . . . Sydes, M. R. (2015). Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019). European urology, 67(6), 1028-1038. https://doi.org/10.1016/j.eururo.2014.09.032

Chicago Style (17th ed.) Citation

James, Nicholas David, et al. "Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)." European Urology 67, no. 6 (2015): 1028-1038. https://doi.org/10.1016/j.eururo.2014.09.032.

MLA (9th ed.) Citation

James, Nicholas David, et al. "Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)." European Urology, vol. 67, no. 6, 2015, pp. 1028-1038, https://doi.org/10.1016/j.eururo.2014.09.032.